Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News and Insights

Showing items 1 to3 of 6

Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Servier, Agilent, Medtronic, and UHS announce significant acquisitions
Insight
Our Take Newsletter
March 16, 2026

Servier, Agilent, Medtronic, and UHS announce significant acquisitions

Learn More
March 16, 2026
IDN trends, challenges, and leadership
Amazon unveils Connect Health platform
Insight
Our Take Newsletter
March 9, 2026

Amazon unveils Connect Health platform

Learn More
March 9, 2026
Digital health and emerging technologies
Big Pharma, home health and digital health companies notch big-ticket deals
Insight
Our Take Newsletter
March 2, 2026

Big Pharma, home health and digital health companies notch big-ticket deals

Learn More
March 2, 2026
Digital health and emerging technologies
Humana’s CenterWell acquires Florida-based primary care provider MaxHealth
Insight
Our Take Newsletter
February 23, 2026

Humana’s CenterWell acquires Florida-based primary care provider MaxHealth

Learn More
February 23, 2026
Value-based care and alternative payment models
A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes
Insight
Our Take Newsletter
February 16, 2026

A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes

Learn More
February 16, 2026
Health policy, CMS initiatives and health economics
Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports
Insight
Our Take Newsletter
February 9, 2026

Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports

Learn More
February 9, 2026
Pharma strategy, engagement, and market access
Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations
Insight
Our Take Newsletter
February 2, 2026

Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Learn More
February 2, 2026
Health policy, CMS initiatives and health economics
Health insurance CEOs catch flak at House hearings on affordability, blame others for high costs
Insight
Our Take Newsletter
January 25, 2026

Health insurance CEOs catch flak at House hearings on affordability, blame others for high costs

Learn More
January 25, 2026
Health policy, CMS initiatives and health economics
Anthropic, OpenAI unveil new AI tools for health care enterprises
Insight
Our Take Newsletter
January 18, 2026

Anthropic, OpenAI unveil new AI tools for health care enterprises

Learn More
January 18, 2026
Digital health and emerging technologies
OpenAI introduces ChatGPT Health to further integrate users' health information
Insight
Our Take Newsletter
January 11, 2026

OpenAI introduces ChatGPT Health to further integrate users' health information

Learn More
January 11, 2026
Digital health and emerging technologies
FDA approves Novo Nordisk’s Wegovy pill
Insight
Our Take Newsletter
January 5, 2026

FDA approves Novo Nordisk’s Wegovy pill

Learn More
January 5, 2026
IDN trends, challenges, and leadership
Another 9 drugmakers agree to most-favored-nation pricing on certain products
Insight
Our Take Newsletter
December 22, 2025

Another 9 drugmakers agree to most-favored-nation pricing on certain products

Learn More
December 22, 2025
Health policy, CMS initiatives and health economics
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.